New Thai Health Minister Promises To Break Drug Patents
This article was originally published in PharmAsia News
Executive Summary
Thailand's new health minister has made it clear he intends to use the country's compulsory licensing law to ensure Thais have access to key drugs at lower prices. Public Health Minister Chaovarat Chanweerakul's stance on the issue had been doubted by non-government organizations that feared he would side with drug makers and not use the CL policy. But at Chaovarat's arrival on the job, he promised he would break patents on life-saving drugs when necessary. (Click here for more
You may also be interested in...
Sanofi Asks Thailand To Review Compulsory Licensing Policy
Sanofi-Aventis sent a request to the previous Thai Minister of Commerce Mingkwan Sangsuwan to review the process of compulsory licensing on patented drugs, Graham Almond, Sanofi-Aventis Thailand general manager told PharmAsia News.
Cullinan Changes Tracks, Moving Lymphoma Bispecific Into Autoimmune
The company will discontinue its trial of the CD19-directed bispecific CLN-978 in NHL and develop it in inflammatory diseases, where it could have an edge over CAR-Ts.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.